[Careers & Partnerships] Date: 2025-06-14 11:25:21 Source:
Author: Dashboard / Analytics Views: 197 times
Waters Corporation (NYSE:WAT) today introduced a new peptide multi-attribute method (MAM) workflow for the Waters™ BioAccord™ LC-MS System,
enabling drug development, manufacturing, and QC scientists
(Editor: NFTs & Metaverse)
